BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37734383)

  • 21. Sustained mTORC1 activity during palbociclib-induced growth arrest triggers senescence in ER+ breast cancer cells.
    Maskey RS; Wang F; Lehman E; Wang Y; Emmanuel N; Zhong W; Jin G; Abraham RT; Arndt KT; Myers JS; Mazurek A
    Cell Cycle; 2021 Jan; 20(1):65-80. PubMed ID: 33356791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of CDK4 sensitizes multidrug resistant ovarian cancer cells to paclitaxel by increasing apoptosiss.
    Gao Y; Shen J; Choy E; Mankin H; Hornicek F; Duan Z
    Cell Oncol (Dordr); 2017 Jun; 40(3):209-218. PubMed ID: 28243976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nobiletin downregulates the SKP2-p21/p27-CDK2 axis to inhibit tumor progression and shows synergistic effects with palbociclib on renal cell carcinoma.
    Chen T; Liu L; Zou Y; Hu X; Zhang W; Zhou T; Luo X; Fu W; Xu J
    Cancer Biol Med; 2021 Feb; 18(1):227-244. PubMed ID: 33628597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The HDAC6/8/10 inhibitor TH34 induces DNA damage-mediated cell death in human high-grade neuroblastoma cell lines.
    Kolbinger FR; Koeneke E; Ridinger J; Heimburg T; Müller M; Bayer T; Sippl W; Jung M; Gunkel N; Miller AK; Westermann F; Witt O; Oehme I
    Arch Toxicol; 2018 Aug; 92(8):2649-2664. PubMed ID: 29947893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactivation of silenced α-N-catenin induces retinoic acid sensitivity in neuroblastoma cells.
    Clark RA; Newton M; Qiao J; Lee S; Chung DH
    Surgery; 2021 Nov; 170(5):1546-1553. PubMed ID: 34092372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Combination of the CDK4/6 Inhibitor, Palbociclib, With the Vitamin D
    Vanhevel J; Verlinden L; Loopmans S; Doms S; Janssens I; Bevers S; Stegen S; Wildiers H; Verstuyf A
    Front Endocrinol (Lausanne); 2022; 13():886238. PubMed ID: 35784555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arsenic trioxide induces the differentiation of retinoic acid-resistant neuroblastoma cells via upregulation of HoxC9.
    Li C; Feng C; Chen Y; Wu P; Li P; Xiong X; Peng X; Wang Z; Li Y
    Adv Clin Exp Med; 2022 Aug; 31(8):903-911. PubMed ID: 35467087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peroxisome proliferator-activated receptor-β/δ inhibits human neuroblastoma cell tumorigenesis by inducing p53- and SOX2-mediated cell differentiation.
    Yao PL; Chen L; Dobrzański TP; Zhu B; Kang BH; Müller R; Gonzalez FJ; Peters JM
    Mol Carcinog; 2017 May; 56(5):1472-1483. PubMed ID: 27996177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined CDK4/6 and Pan-mTOR Inhibition Is Synergistic Against Intrahepatic Cholangiocarcinoma.
    Song X; Liu X; Wang H; Wang J; Qiao Y; Cigliano A; Utpatel K; Ribback S; Pilo MG; Serra M; Gordan JD; Che L; Zhang S; Cossu A; Porcu A; Pascale RM; Dombrowski F; Hu H; Calvisi DF; Evert M; Chen X
    Clin Cancer Res; 2019 Jan; 25(1):403-413. PubMed ID: 30084835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apoptosis of N-type neuroblastoma cells after differentiation with 9-cis-retinoic acid and subsequent washout.
    Lovat PE; Irving H; Annicchiarico-Petruzzelli M; Bernassola F; Malcolm AJ; Pearson AD; Melino G; Redfern CP
    J Natl Cancer Inst; 1997 Mar; 89(6):446-52. PubMed ID: 9091647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HOXC9 links cell-cycle exit and neuronal differentiation and is a prognostic marker in neuroblastoma.
    Mao L; Ding J; Zha Y; Yang L; McCarthy BA; King W; Cui H; Ding HF
    Cancer Res; 2011 Jun; 71(12):4314-24. PubMed ID: 21507931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glial cell line-derived neurotrophic factor (GDNF) family ligands reduce the sensitivity of neuroblastoma cells to pharmacologically induced cell death, growth arrest and differentiation.
    Hansford LM; Marshall GM
    Neurosci Lett; 2005 Dec; 389(2):77-82. PubMed ID: 16125842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma.
    Bollard J; Miguela V; Ruiz de Galarreta M; Venkatesh A; Bian CB; Roberto MP; Tovar V; Sia D; Molina-Sánchez P; Nguyen CB; Nakagawa S; Llovet JM; Hoshida Y; Lujambio A
    Gut; 2017 Jul; 66(7):1286-1296. PubMed ID: 27849562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinoic acid downregulates Rae1 leading to APC(Cdh1) activation and neuroblastoma SH-SY5Y differentiation.
    Cuende J; Moreno S; Bolaños JP; Almeida A
    Oncogene; 2008 May; 27(23):3339-44. PubMed ID: 18212744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-cell growth and anti-cancer stem cell activity of the CDK4/6 inhibitor palbociclib in breast cancer cells.
    Kishino E; Ogata R; Saitoh W; Koike Y; Ohta Y; Kanomata N; Kurebayashi J
    Breast Cancer; 2020 May; 27(3):415-425. PubMed ID: 31823286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CDK6 Is a Therapeutic Target in Myelofibrosis.
    Dutta A; Nath D; Yang Y; Le BT; Mohi G
    Cancer Res; 2021 Aug; 81(16):4332-4345. PubMed ID: 34145036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma.
    Siaw JT; Javanmardi N; Van den Eynden J; Lind DE; Fransson S; Martinez-Monleon A; Djos A; Sjöberg RM; Östensson M; Carén H; Trøen G; Beiske K; Berbegall AP; Noguera R; Lai WY; Kogner P; Palmer RH; Hallberg B; Martinsson T
    Cell Rep; 2020 Sep; 32(12):108171. PubMed ID: 32966799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Redox balance influences differentiation status of neuroblastoma in the presence of all-trans retinoic acid.
    Silvis AM; McCormick ML; Spitz DR; Kiningham KK
    Redox Biol; 2016 Apr; 7():88-96. PubMed ID: 26678800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.
    Ponzoni M; Bocca P; Chiesa V; Decensi A; Pistoia V; Raffaghello L; Rozzo C; Montaldo PG
    Cancer Res; 1995 Feb; 55(4):853-61. PubMed ID: 7850799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER
    Petroni G; Buqué A; Yamazaki T; Bloy N; Liberto MD; Chen-Kiang S; Formenti SC; Galluzzi L
    Clin Cancer Res; 2021 Apr; 27(7):1855-1863. PubMed ID: 33495311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.